Abstract
Intracerebral hemorrhage (ICH) is a devastating subtype of stroke with a high mortality rate, for which there currently is no effective treatment. A perihematomal edema caused by an intense inflammatory reaction is more deleterious than the hematoma itself and can result in neurological deterioration and death. Ceria nanoparticles (CeNPs) are potent free radical scavengers with potential for biomedical applications. As oxidative stress plays a major role in post-ICH inflammation, we hypothesized that CeNPs might protect against ICH. To test this hypothesis, core CeNPs were synthesized using a modified reverse micelle method and covered with phospholipid-polyethylene glycol (PEG) to achieve biocompatibility. We investigated whether our custom-made biocompatible CeNPs have protective effects against ICH. The CeNPs reduced oxidative stress, hemin-induced cytotoxicity, and inflammation in vitro. In a rodent ICH model, intravenously administered CeNPs were mainly distributed in the hemorrhagic hemisphere, suggesting that they could diffuse through the damaged blood–brain barrier. Moreover, CeNPs attenuated microglia/macrophage recruitment around the hemorrhagic lesion and inflammatory protein expression. Finally, CeNP treatment reduced the brain edema by 68.4% as compared to the control. These results reveal the great potential of CeNPs as a novel therapeutic agent for patients with ICH.
Similar content being viewed by others
References
Qureshi, A. I.; Tuhrim, S.; Broderick, J. P.; Batjer, H. H.; Hondo, H.; Hanley, D. F. Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 2001, 344, 1450–1460.
Labovitz, D. L.; Halim, A.; Boden-Albala, B.; Hauser, W. A.; Sacco, R. L. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 2005, 65, 518–522.
Qureshi, A. I.; Mendelow, A. D.; Hanley, D. F. Intracerebral haemorrhage. Lancet 2009, 373, 1632–1644.
Hemphill, J. C.; Greenberg, S. M.; Anderson, C. S.; Becker, K.; Bendok, B. R.; Cushman, M.; Fung, G. L.; Goldstein, J. N.; Macdonald, R. L.; Mitchell, P. H. et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2015, 46, 2032–2060.
Mendelow, A. D.; Gregson, B. A.; Fernandes, H. M.; Murray, G. D.; Teasdale, G. M.; Hope, D. T.; Karimi, A.; Shaw, M. D. M.; Barer, D. H. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet 2005, 365, 387–397.
Mayer, S. A.; Brun, N. C.; Begtrup, K.; Broderick, J.; Davis, S.; Diringer, M. N.; Skolnick, B. E.; Steiner, T. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 2008, 358, 2127–2137.
Aronowski, J.; Zhao, X. R. Molecular pathophysiology of cerebral hemorrhage: Secondary brain injury. Stroke 2011, 42, 1781–1786.
Masada, T.; Hua, Y.; Xi, G. H.; Yang, G. Y.; Hoff, J. T.; Keep, R. F. Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J. Neurosurg. 2001, 95, 680–686.
Hua, Y.; Keep, R. F.; Hoff, J. T.; Xi, G. H. Brain injury after intracerebral hemorrhage: The role of thrombin and iron. Stroke 2007, 38, 759–762.
Keep, R. F.; Hua, Y.; Xi, G. H. Intracerebral haemorrhage: Mechanisms of injury and therapeutic targets. Lancet Neurol. 2012, 11, 720–731.
Dahle, J. T.; Arai, Y. Environmental geochemistry of cerium: Applications and toxicology of cerium oxide nanoparticles. Int. J. Environ. Res. Public Health 2015, 12, 1253–1278.
Chen, J. P.; Patil, S.; Seal, S.; McGinnis, J. F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 2006, 1, 142–150.
Das, M.; Patil, S.; Bhargava, N.; Kang, J.-F.; Riedel, L. M.; Seal, S.; Hickman, J. J. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28, 1918–1925.
Chen, S. Z.; Hou, Y. J.; Cheng, G.; Zhang, C. M.; Wang, S. X.; Zhang, J. C. Cerium oxide nanoparticles protect endothelial cells from apoptosis induced by oxidative stress. Biol. Trace Elem. Res. 2013, 154, 156–166.
Dowding, J. M.; Das, S.; Kumar, A.; Dosani, T.; McCormack, R.; Gupta, A.; Sayle, T. X. T.; Sayle, D. C.; von Kalm, L.; Seal, S. et al. Cellular interaction and toxicity depend on physicochemical properties and surface modification of redox-active nanomaterials. ACS Nano 2013, 7, 4855–4868.
Selvaraj, V.; Nepal, N.; Rogers, S.; Manne, N. D. P. K.; Arvapalli, R.; Rice, K. M.; Asano, S.; Fankhanel, E.; Ma, J. J.; Shokuhfar, T. et al. Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles. Biomaterials 2015, 59, 160–171.
Hirst, S. M.; Karakoti, A. S.; Tyler, R. D.; Sriranganathan, N.; Seal, S.; Reilly, C. M. Anti-inflammatory properties of cerium oxide nanoparticles. Small 2009, 5, 2848–2856.
Manne, N. D.; Arvapalli, R.; Nepal, N.; Thulluri, S.; Selvaraj, V.; Shokuhfar, T.; He, K.; Rice, K. M.; Asano, S.; Maheshwari, M. et al. Therapeutic potential of cerium oxide nanoparticles for the treatment of peritonitis induced by polymicrobial insult in Sprague–Dawley rats. Crit. Care Med. 2015, 43, e477–e489.
Manne, N. D. P. K.; Arvapalli, R.; Nepal, N.; Shokuhfar, T.; Rice, K. M.; Asano, S.; Blough, E. R. Cerium oxide nanoparticles attenuate acute kidney injury induced by intra-abdominal infection in Sprague–Dawley rats. J. Nanobiotechnology 2015, 13, 75.
Kyosseva, S. V.; Chen, L. J.; Seal, S.; McGinnis, J. F. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice. Exp. Eye Res. 2013, 116, 63–74.
Kim, C. K.; Kim, T.; Choi, I. Y.; Soh, M.; Kim, D.; Kim, Y. J.; Jang, H.; Yang, H. S.; Kim, J. Y.; Park, H. K. et al. Ceria nanoparticles that can protect against ischemic stroke. Angew. Chem., Int. Ed. 2012, 51, 11039–11043.
Mracsko, E.; Veltkamp, R. Neuroinflammation after intracerebral hemorrhage. Front. Cell. Neurosci. 2014, 8, 388.
Chao, C. C.; Hu, S. X.; Sheng, W. S.; Bu, D. F.; Bukrinsky, M. I.; Peterson, P. K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 1996, 16, 276–284.
Sinensky, M. C.; Leiser, A. L.; Babich, H. Oxidative stress aspects of the cytotoxicity of carbamide peroxide: In vitro studies. Toxicol. Lett. 1995, 75, 101–109.
Grossetete, M.; Rosenberg, G. A. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse. J. Cereb. Blood Flow Metab. 2008, 28, 752–763.
Aguilar, M. I.; Brott, T. G. Update in intracerebral hemorrhage. Neurohospitalist 2011, 1, 148–159.
Kim, C. K.; Ryu, W. S.; Choi, I. Y.; Kim, Y. J.; Rim, D.; Kim, B. J.; Jang, H.; Yoon, B. W.; Lee, S. H. Detrimental effects of leptin on intracerebral hemorrhage via the STAT3 signal pathway. J. Cereb. Blood Flow Metab. 2013, 33, 944–953.
Jung, K. H.; Chu, K.; Jeong, S. W.; Han, S. Y.; Lee, S. T.; Kim, J. Y.; Kim, M.; Roh, J. K. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 2004, 35, 1744–1749.
Huang, F.-P.; Xi, G. H.; Keep, R. F.; Hua, Y.; Nemoianu, A.; Hoff, J. T. Brain edema after experimental intracerebral hemorrhage: Role of hemoglobin degradation products. J. Neurosurg. 2002, 96, 287–293.
Crow, J. P. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997, 1, 145–157.
Grisham, M. B.; Jourd’Heuil, D.; Wink, D. A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am. J. Physiol. 1999, 276, G315–G321.
Laird, M. D.; Wakade, C.; Alleyne, C. H., Jr.; Dhandapani, K. M. Hemin-induced necroptosis involves glutathione depletion in mouse astrocytes. Free Radic. Biol. Med. 2008, 45, 1103–1114.
Mitchell, J. A.; Warner, T. D. Cyclo-oxygenase-2: Pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br. J. Pharmacol. 1999, 128, 1121–1132.
Gavrieli, Y.; Sherman, Y.; Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992, 119, 493–501.
Ljosa, V.; Carpenter, A. E. Introduction to the quantitative analysis of two-dimensional fluorescence microscopy images for cell-based screening. PLoS Comput. Biol. 2009, 5, e1000603.
MacLellan, C. L.; Silasi, G.; Poon, C. C.; Edmundson, C. L.; Buist, R.; Peeling, J.; Colbourne, F. Intracerebral hemorrhage models in rat: Comparing collagenase to blood infusion. J. Cereb. Blood Flow Metab. 2008, 28, 516–525.
Karakoti, A. S.; Kuchibhatla, S. V. N. T.; Babu, K. S.; Seal, S. Direct synthesis of nanoceria in aqueous polyhydroxyl solutions. J. Phys. Chem. C 2007, 111, 17232–17240.
Karakoti, A. S.; Monteiro-Riviere, N. A.; Aggarwal, R.; Davis, J. P.; Narayan, R. J.; Self, W. T.; McGinnis, J.; Seal, S. Nanoceria as antioxidant: Synthesis and biomedical applications. JOM 2008, 60, 33–37.
Poma, A.; Ragnelli, A. M.; de Lapuente, J.; Ramos, D.; Borras, M.; Aimola, P.; Di Gioacchino, M.; Santucci, S.; De Marzi, L. In vivo inflammatory effects of ceria nanoparticles on CD-1 mouse: Evaluation by hematological, histological, and TEM analysis. J. Immunol. Res. 2014, 2014, 361419.
Alili, L.; Sack, M.; von Montfort, C.; Giri, S.; Das, S.; Carroll, K. S.; Zanger, K.; Seal, S.; Brenneisen, P. Downregulation of tumor growth and invasion by redox-active nanoparticles. Antioxid. Redox Signal. 2013, 19, 765–778.
Park, E.-J.; Choi, J.; Park, Y.-K.; Park, K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 2008, 245, 90–100.
Kazui, S.; Naritomi, H.; Yamamoto, H.; Sawada, T.; Yamaguchi, T. Enlargement of spontaneous intracerebral hemorrhage: Incidence and time course. Stroke 1996, 27, 1783–1787.
Goldstein, L.; Teng, Z. P.; Zeserson, E.; Patel, M.; Regan, R. F. Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J Neurosci. Res. 2003, 73, 113–121.
Wagner, K. R.; Sharp, F. R.; Ardizzone, T. D.; Lu, A. G.; Clark, J. F. Heme and iron metabolism: Role in cerebral hemorrhage. J. Cereb. Blood Flow Metab. 2003, 23, 629–652.
Kress, G. J.; Dineley, K. E.; Reynolds, I. J. The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J. Neurosci. 2002, 22, 5848–5855.
Barbieri, S. S.; Eligini, S.; Brambilla, M.; Tremoli, E.; Colli, S. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: Critical role of NADPH oxidase. Cardiovasc. Res. 2003, 60, 187–197.
Campuzano, O.; Castillo-Ruiz, M. M.; Acarin, L.; Castellano, B.; Gonzalez, B. Distinct pattern of microglial response, cyclooxygenase-2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage. J. Neurosci. Res. 2008, 86, 3170–3183.
Meyer, M.; Schreck, R.; Baeuerle, P. A. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 1993, 12, 2005–2015.
Ding, R.; Chen, Y. Z.; Yang, S.; Deng, X. Q.; Fu, Z. H.; Feng, L.; Cai, Y. Q.; Du, M. X.; Zhou, Y. X.; Tang, Y. P. Blood-brain barrier disruption induced by hemoglobin in vivo: Involvement of up-regulation of nitric oxide synthase and peroxynitrite formation. Brain Res. 2014, 1571, 25–38.
Wagner, K. R.; Packard, B. A.; Hall, C. L.; Smulian, A. G.; Linke, M. J.; de Courten-Myers, G. M.; Packard, L. M.; Hall, N. C. Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma. Dev. Neurosci. 2002, 24, 154–160.
Mittal, M.; Siddiqui, M. R.; Tran, K.; Reddy, S. P.; Malik, A. B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Sign. 2014, 20, 1126–1167.
Selvaraj, V.; Manne, N. D.; Arvapalli, R.; Rice, K. M.; Nandyala, G.; Fankenhanel, E.; Blough, E. R. Effect of cerium oxide nanoparticles on sepsis induced mortality and NF-?B signaling in cultured macrophages. Nanomedicine 2015, 10, 1275–1288.
Hu, X.; Tao, C. Y.; Gan, Q.; Zheng, J.; Li, H.; You, C. Oxidative stress in intracerebral hemorrhage: Sources, mechanisms, and therapeutic targets. Oxid. Med. Cell. Longev. 2016, 2016, 3215391.
Zhao, X. R.; Song, S.; Sun, G. H.; Strong, R.; Zhang, J.; Grotta, J. C.; Aronowski, J. Neuroprotective role of haptoglobin after intracerebral hemorrhage. J. Neurosci. 2009, 29, 15819–15827.
Nakamura, T.; Keep, R. F.; Hua, Y.; Schallert, T.; Hoff, J. T.; Xi, G. H. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J. Neurosurg. 2004, 100, 672–678.
Lin, S.; Yin, Q.; Zhong, Q.; Lv, F.-L.; Zhou, Y.; Li, J.-Q.; Wang, J.-Z.; Su, B. Y.; Yang, Q.-W. Heme activates TLR4- mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J. Neuroinflamm. 2012, 9, 46.
Gong, C.; Ennis, S. R.; Hoff, J. T.; Keep, R. F. Inducible cyclooxygenase-2 expression after experimental intracerebral hemorrhage. Brain Res. 2001, 901, 38–46.
Wu, B.; Chen, X. H.; He, B.; Liu, S. Y.; Li, Y. F.; Wang, Q. X.; Gao, H. J.; Wang, S. F.; Liu, J. B.; Zhang, S. C. et al. ROS are critical for endometrial breakdown via NF-κB–COX-2 signaling in a female mouse menstrual-like model. Endocrinology 2014, 155, 3638–3648.
Zhao, X. R.; Zhang, Y. J.; Strong, R.; Zhang, J.; Grotta, J. C.; Aronowski, J. Distinct patterns of intracerebral hemorrhageinduced alterations in NF-?B subunit, iNOS, and COX-2 expression. J. Neurochem. 2007, 101, 652–663.
Taylor, R. A.; Sansing, L. H. Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin. Dev. Immunol. 2013, 2013, 746068.
Fortes, G. B.; Alves, L. S.; de Oliveira, R.; Dutra, F. F.; Rodrigues, D.; Fernandez, P. L.; Souto-Padron, T.; De Rosa, M. J.; Kelliher, M.; Golenbock, D. et al. Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood 2012, 119, 2368–2375.
Fleury, C.; Mignotte, B.; Vayssière, J.-L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002, 84, 131–141.
Orrenius, S. Reactive oxygen species in mitochondriamediated cell death. Drug Metab. Rev. 2007, 39, 443–455.
Bergsbaken, T.; Fink, S. L.; Cookson, B. T. Pyroptosis: Host cell death and inflammation. Nat. Rev. Microbiol. 2009, 7, 99–109.
Lockman, P. R.; Mumper, R. J.; Khan, M. A.; Allen, D. D. Nanoparticle technology for drug delivery across the bloodbrain barrier. Drug Dev. Ind. Pharm. 2002, 28, 1–13.
Wang, J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog. Neurobiol. 2010, 92, 463–477.
Dahnovici, R. M.; Pintea, I. L.; Malaescu, D. G.; Busuioc, C. J.; Predescu, A.; Mogoanta, L. Microscopic aspects of macrophage system cells in hemorrhagic stroke in humans. Rom. J. Morphol. Embryol. 2011, 52, 1249–1253.
Chu, K.; Jeong, S. W.; Jung, K. H.; Han, S. Y.; Lee, S. T.; Kim, M.; Roh, J. K. Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J. Cereb. Blood Flow Metab. 2004, 24, 926–933.
Xi, G. H.; Wagner, K. R.; Keep, R. F.; Hua, Y.; de Courten-Myers, G. M.; Broderick, J. P.; Brott, T. G.; Hoff, J. T.; Muizelaar, J. P. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke 1998, 29, 2580–2586.
Xi, G. H.; Reiser, G.; Keep, R. F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: Deleterious or protective? J. Neurochem. 2003, 84, 3–9.
Wu, H.; Wu, T.; Xu, X. Y.; Wang, J.; Wang, J. Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 2011, 31, 1243–1250.
Sykora, M.; Diedler, J.; Turcani, P.; Rupp, A.; Steiner, T. Subacute perihematomal edema in intracerebral hemorrhage is associated with impaired blood pressure regulation. J. Neurol. Sci. 2009, 284, 108–112.
Acknowledgements
This work was supported by grants of the followings: The Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), the Ministry of Health & Welfare, Republic of Korea (No. HI14C0211), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. NRF-2015R1A2A2A 01007770), and the Institute for Basic Science (IBS), Republic of Korea (No. IBS-R006-D1).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
12274_2017_1478_MOESM1_ESM.pdf
Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage
Rights and permissions
About this article
Cite this article
Kang, DW., Kim, C.K., Jeong, HG. et al. Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage. Nano Res. 10, 2743–2760 (2017). https://doi.org/10.1007/s12274-017-1478-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-017-1478-6